Li Bang International Agrees to Buy 50.1% Stake in Jiangsu Xinsheng Synthetic Materials
The proposed acquisition gives Li Bang International a majority stake in Jiangsu Xinsheng Synthetic Materials.
Related stories
CVS to Split Retail Pharmacies From Insurance and Pharmacy-Benefit Operations
CVS Health will split into two companies, separating its retail pharmacies from its insurance and pharmacy-benefit operations, the Wall Street Journal reported, citing people famil
M impact | MNA | Nov 03, 2026, 11:28 PM UTC
Fibra MTY Raises Stake in Fibra Macquarie México to 98.12%
Fibra MTY increased its stake in Fibra Macquarie México to 98.12% after a tender offer.
M impact | MNA | Nov 03, 2026, 11:19 PM UTC
CVS Health considers splitting pharmacy and insurance businesses
The Financial Times, citing people familiar with the matter, reported that CVS Health is considering separating its retail pharmacy and insurance businesses.
M impact | MNA | Nov 03, 2026, 11:14 PM UTC
FT: CVS Health studies separating retail pharmacy and insurance businesses
The Financial Times reports that CVS Health is studying a possible separation of its retail pharmacy and insurance businesses.
M impact | MNA | Nov 03, 2026, 11:14 PM UTC
CVS breakup set for first half of 2028, WSJ reports
M impact | MNA | Nov 03, 2026, 11:14 PM UTC
Curaleaf Says Its Aurora Takeover Bid Still Stands After Rival Deal
Curaleaf said its offer to acquire Aurora Cannabis remains outstanding after Aurora accepted Organigram Global’s buyout offer.
M impact | MNA | Nov 03, 2026, 11:11 PM UTC